HBV Mutation Detail Information

> T148P Search Result


Mutation Information
Mutation Site T148P
Mutation Type Amino acid level
Gene/Protein/Region Type S
Genotype/Subtype A
Immune Escape Y
Country Ethiopia
Literature Information
PubMed PMID 27354181
Disease HBV-HIV coinfection
Published Year 2017
Journal Antiviral therapy
Title HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
Author Belyhun Y,Maier M,Liebert UG
Evidence In particular, the 'a' determinant surface gene mutations (sT125S, sA128V, sQ129H/R, sT131I, sC137S, sT143M, sD144D/E, sG145R, sT148P) and the majority of clustered/multiple as well as drug selected immune escape HBsAg mutations were more prevalent in HBV-HIV-coinfected individuals.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation